Opti Capital Management, LP Quant / Systematic

Location: New York, NY

CIK: 0001738654 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 16, 2021

Total Value: $897M (0.1% shares, 99.9% debt)

Holdings (34)

— TERADYNE INC 10.8%

Value $96.47M Shares 25,439,000 Est. Cost $4.52 Unrealized —

— NUANCE COMMUNICATIONS INC 8.0%

Value $71.81M Shares 38,565,000 Est. Cost $1.66 Unrealized —

— DOCUSIGN INC 8.0%

Value $71.5M Shares 22,933,000 Est. Cost $3.03 Unrealized —

— SAREPTA THERAPEUTICS INC 7.6%

Value $68.03M Shares 27,809,000 Est. Cost $2.40 Unrealized —

— 8X8 INC NEW 7.4%

Value $66.45M Shares 45,450,000 Est. Cost $1.63 Unrealized —

— NEW RELIC INC 5.3%

Value $47.51M Shares 48,091,000 Est. Cost $1.22 Unrealized —

— RAPID7 INC 5.1%

Value $45.9M Shares 21,000,000 Est. Cost $2.44 Unrealized —

— ZILLOW GROUP INC 4.7%

Value $42.5M Shares 14,200,000 Est. Cost $2.99 Unrealized —

— SUPERNUS PHARMACEUTICALS INC 4.1%

Value $36.96M Shares 38,801,000 Est. Cost $1.77 Unrealized —

— FIREEYE INC 3.8%

Value $34.4M Shares 34,833,000 Est. Cost $2.09 Unrealized —

— EXACT SCIENCES CORP 3.7%

Value $33.1M Shares 17,483,000 Est. Cost $1.89 Unrealized —

— VERINT SYS INC 3.6%

Value $32.6M Shares 29,740,000 Est. Cost $2.30 Unrealized —

— AVAYA HLDGS CORP 2.7%

Value $24.62M Shares 23,500,000 Est. Cost $0.95 Unrealized —

— SYNAPTICS INC 2.7%

Value $24.12M Shares 17,500,000 Est. Cost $2.37 Unrealized —

— LUMENTUM HLDGS INC 2.4%

Value $21.5M Shares 13,000,000 Est. Cost $1.65 Unrealized —

— REALPAGE INC 2.3%

Value $20.89M Shares 10,000,000 Est. Cost $2.09 Unrealized —

— RAMBUS INC DEL 1.7%

Value $15.26M Shares 13,500,000 Est. Cost $1.57 Unrealized —

— NUTANIX INC 1.6%

Value $14.05M Shares 13,873,000 Est. Cost $1.99 Unrealized —

— CYTOKINETICS INC 1.6%

Value $14.02M Shares 6,500,000 Est. Cost $4.95 Unrealized —

— IONIS PHARMACEUTICALS INC 1.5%

Value $13.22M Shares 12,900,000 Est. Cost $1.03 Unrealized —

— RETROPHIN INC 1.3%

Value $12.08M Shares 11,905,000 Est. Cost $1.47 Unrealized —

— JAZZ INVESTMENTS I LTD 1.3%

Value $11.71M Shares 10,909,000 Est. Cost $2.00 Unrealized —

— PTC THERAPEUTICS INC 1.2%

Value $10.95M Shares 8,500,000 Est. Cost $2.51 Unrealized —

— OMEROS CORP 1.1%

Value $9.942M Shares 9,200,000 Est. Cost $1.93 Unrealized —

— APELLIS PHARMACEUTICALS INC 0.9%

Value $8.414M Shares 5,000,000 Est. Cost $1.68 Unrealized —

— VONAGE HLDGS CORP 0.9%

Value $8.179M Shares 7,505,000 Est. Cost $1.08 Unrealized —

— OPKO HEALTH INC 0.9%

Value $7.844M Shares 6,200,000 Est. Cost $2.12 Unrealized —

— VOCERA COMMUNICATIONS INC 0.8%

Value $7.069M Shares 5,000,000 Est. Cost $1.41 Unrealized —

— FIREEYE INC 0.8%

Value $6.87M Shares 5,634,000 Est. Cost $1.22 Unrealized —

— IRONWOOD PHARMACEUTICALS INC 0.7%

Value $5.961M Shares 5,300,000 Est. Cost $0.99 Unrealized —

— INTERCEPT PHARMACEUTICALS IN 0.5%

Value $4.25M Shares 7,000,000 Est. Cost $0.71 Unrealized —

— RADIUS HEALTH INC 0.4%

Value $3.975M Shares 4,407,000 Est. Cost $0.82 Unrealized —

— PROOFPOINT INC 0.4%

Value $3.932M Shares 3,500,000 Est. Cost $1.12 Unrealized —

T AT&T INC 0.1%

Value $1.007M Shares 35,000 Est. Cost $15.38 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	TERADYNE INC	25,439,000	$96.47M	10.8%	$4.52	—	NOTE 1.250%12/1	880770AG7
—	NUANCE COMMUNICATIONS INC	38,565,000	$71.81M	8.0%	$1.66	—	DBCV 1.000%12/1	67020YAK6
—	DOCUSIGN INC	22,933,000	$71.5M	8.0%	$3.03	—	NOTE 0.500% 9/1	256163AB2
—	SAREPTA THERAPEUTICS INC	27,809,000	$68.03M	7.6%	$2.40	—	DBCV 1.500%11/1	803607AB6
—	8X8 INC NEW	45,450,000	$66.45M	7.4%	$1.63	—	NOTE 0.500% 2/0	282914AB6
—	NEW RELIC INC	48,091,000	$47.51M	5.3%	$1.22	—	NOTE 0.500% 5/0	64829BAB6
—	RAPID7 INC	21,000,000	$45.9M	5.1%	$2.44	—	NOTE 1.250% 8/0	753422AB0
—	ZILLOW GROUP INC	14,200,000	$42.5M	4.7%	$2.99	—	NOTE 0.750% 9/0	98954MAE1
—	SUPERNUS PHARMACEUTICALS INC	38,801,000	$36.96M	4.1%	$1.77	—	NOTE 0.625% 4/0	868459AD0
—	FIREEYE INC	34,833,000	$34.4M	3.8%	$2.09	—	NOTE 1.625% 6/0	31816QAD3
—	EXACT SCIENCES CORP	17,483,000	$33.1M	3.7%	$1.89	—	NOTE 1.000% 1/1	30063PAA3
—	VERINT SYS INC	29,740,000	$32.6M	3.6%	$2.30	—	NOTE 1.500% 6/0	92343XAA8
—	AVAYA HLDGS CORP	23,500,000	$24.62M	2.7%	$0.95	—	NOTE 2.250% 6/1	05351XAB7
—	SYNAPTICS INC	17,500,000	$24.12M	2.7%	$2.37	—	NOTE 0.500% 6/1	87157DAD1
—	LUMENTUM HLDGS INC	13,000,000	$21.5M	2.4%	$1.65	—	NOTE 0.250% 3/1	55024UAB5
—	REALPAGE INC	10,000,000	$20.89M	2.3%	$2.09	—	NOTE 1.500%11/1	75606NAB5
—	RAMBUS INC DEL	13,500,000	$15.26M	1.7%	$1.57	—	NOTE 1.375% 2/0	750917AG1
—	NUTANIX INC	13,873,000	$14.05M	1.6%	$1.99	—	NOTE 1/1	67059NAB4
—	CYTOKINETICS INC	6,500,000	$14.02M	1.6%	$4.95	—	NOTE 4.000%11/1	23282WAA8
—	IONIS PHARMACEUTICALS INC	12,900,000	$13.22M	1.5%	$1.03	—	NOTE 0.125%12/1	462222AB6
—	RETROPHIN INC	11,905,000	$12.08M	1.3%	$1.47	—	NOTE 2.500% 9/1	761299AB2
—	JAZZ INVESTMENTS I LTD	10,909,000	$11.71M	1.3%	$2.00	—	NOTE 1.500% 8/1	472145AD3
—	PTC THERAPEUTICS INC	8,500,000	$10.95M	1.2%	$2.51	—	NOTE 3.000% 8/1	69366JAB7
—	OMEROS CORP	9,200,000	$9.942M	1.1%	$1.93	—	NOTE 6.250%11/1	682143AE2
—	APELLIS PHARMACEUTICALS INC	5,000,000	$8.414M	0.9%	$1.68	—	NOTE 3.500% 9/1	03753UAB2
—	VONAGE HLDGS CORP	7,505,000	$8.179M	0.9%	$1.08	—	NOTE 1.750% 6/0	92886TAJ1
—	OPKO HEALTH INC	6,200,000	$7.844M	0.9%	$2.12	—	NOTE 4.500% 2/1	68375NAD5
—	VOCERA COMMUNICATIONS INC	5,000,000	$7.069M	0.8%	$1.41	—	NOTE 1.500% 5/1	92857FAB3
—	FIREEYE INC	5,634,000	$6.87M	0.8%	$1.22	—	NOTE 0.875% 6/0	31816QAF8
—	IRONWOOD PHARMACEUTICALS INC	5,300,000	$5.961M	0.7%	$0.99	—	NOTE 0.750% 6/1	46333XAF5
—	INTERCEPT PHARMACEUTICALS IN	7,000,000	$4.25M	0.5%	$0.71	—	NOTE 2.000% 5/1	45845PAB4
—	RADIUS HEALTH INC	4,407,000	$3.975M	0.4%	$0.82	—	NOTE 3.000% 9/0	750469AA6
—	PROOFPOINT INC	3,500,000	$3.932M	0.4%	$1.12	—	NOTE 0.250% 8/1	743424AF0
T	AT&T INC	35,000	$1.007M	0.1%	$15.38	0.0%	COM	00206R102